Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marius Brits

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|June 18, 2014
The risk of recrystallization: changes to the toxicity and morphology of pyrimethamineZak Perold, Mino R Caira, Marius Brits
Pharmaceutics|December 31, 2025
Cracking the Skin Barrier: Models and Methods Driving Dermal Drug DeliveryFrancelle Bouwer, Marius Brits, Joe M Viljoen
Methods and Protocols|February 20, 2026
RP-DAD-HPLC Method for Quantitative Analysis of Clofazimine and Pyrazinamide for Inclusion in Fixed-Dose Combination Topical Drug Delivery SystemMarius Brits, Francelle Bouwer, Joe M Viljoen
Journal of Pharmaceutical Sciences|August 20, 2009
Characterization of polymorph transformations that decrease the stability of tablets containing the WHO essential drug mebendazoleMarius Brits, Wilna Liebenberg, Melgardt M de Villiers
Pharmaceuticals (Basel, Switzerland)|February 27, 2026
Quality-by-Design Development of a Clofazimine-Pyrazinamide Dermal Emulsion and Its Diffusion Behavior in Strat-M<sup>®</sup> and Human SkinFrancelle Bouwer, Marius Brits, Daniélle van Staden, et al.
Pharmaceutics|June 27, 2025
Formulation of Topical Drug Delivery Systems Containing a Fixed-Dose Isoniazid-Rifampicin Combination Using the Self-Emulsification MechanismMelissa van Deventer, Richard K Haynes, Marius Brits, et al.
International Journal of Pharmaceutics|October 4, 2005
Comparison of the aqueous solubilization of practically insoluble niclosamide by polyamidoamine (PAMAM) dendrimers and cyclodextrinsBharathi Devarakonda, Ronald A Hill, Wilna Liebenberg, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|June 18, 2014
The risk of recrystallization: changes to the toxicity and morphology of pyrimethamineZak Perold, Mino R Caira, Marius Brits
Pharmaceutics|December 31, 2025
Cracking the Skin Barrier: Models and Methods Driving Dermal Drug DeliveryFrancelle Bouwer, Marius Brits, Joe M Viljoen
Methods and Protocols|February 20, 2026
RP-DAD-HPLC Method for Quantitative Analysis of Clofazimine and Pyrazinamide for Inclusion in Fixed-Dose Combination Topical Drug Delivery SystemMarius Brits, Francelle Bouwer, Joe M Viljoen
Journal of Pharmaceutical Sciences|August 20, 2009
Characterization of polymorph transformations that decrease the stability of tablets containing the WHO essential drug mebendazoleMarius Brits, Wilna Liebenberg, Melgardt M de Villiers
Pharmaceuticals (Basel, Switzerland)|February 27, 2026
Quality-by-Design Development of a Clofazimine-Pyrazinamide Dermal Emulsion and Its Diffusion Behavior in Strat-M<sup>®</sup> and Human SkinFrancelle Bouwer, Marius Brits, Daniélle van Staden, et al.
Pharmaceutics|June 27, 2025
Formulation of Topical Drug Delivery Systems Containing a Fixed-Dose Isoniazid-Rifampicin Combination Using the Self-Emulsification MechanismMelissa van Deventer, Richard K Haynes, Marius Brits, et al.
International Journal of Pharmaceutics|October 4, 2005
Comparison of the aqueous solubilization of practically insoluble niclosamide by polyamidoamine (PAMAM) dendrimers and cyclodextrinsBharathi Devarakonda, Ronald A Hill, Wilna Liebenberg, et al.
Pageof 1